Predicting Patient-Specific Radiotherapy Protocols Based on Mathematical Model Choice for Proliferation Saturation Index

Radiation is commonly used in cancer treatment. Over 50% of all cancer patients will undergo radiotherapy (RT) as part of cancer care. Scientific advances in RT have primarily focused on the physical characteristics of treatment including beam quality and delivery. Only recently have inroads been made into utilizing tumor biology and radiobiology to design more appropriate RT protocols. Tumors are composites of proliferating and growth-arrested cells, and overall response depends on their respective proportions at irradiation. Prokopiou et al. (Radiat Oncol 10:159, 2015) developed the concept of the proliferation saturation index (PSI) to augment the clinical decision process associated with RT. This framework is based on the application of the logistic equation to pre-treatment imaging data in order to estimate a patient-specific tumor carrying capacity, which is then used to recommend a specific RT protocol. It is unclear, however, how dependent clinical recommendations are on the underlying tumor growth law. We discuss a PSI framework with a generalized logistic equation that can capture kinetics of different well-known growth laws including logistic and Gompertzian growth. Estimation of model parameters on the basis of clinical data revealed that the generalized logistic model can describe data equally well for a wide range of the generalized logistic exponent value. Clinical recommendations based on the calculated PSI, however, are strongly dependent on the specific growth law assumed. Our analysis suggests that the PSI framework may best be utilized in clinical practice when the underlying tumor growth law is known, or when sufficiently many tumor growth models suggest similar fractionation protocols.

[1]  Ping Wang,et al.  A Mathematical Model of Tumor Volume Changes during Radiotherapy , 2013, TheScientificWorldJournal.

[2]  Kujtim Latifi,et al.  A proliferation saturation index to predict radiation response and personalize radiotherapy fractionation , 2015, Radiation Oncology.

[3]  John M. L. Ebos,et al.  Classical Mathematical Models for Description and Prediction of Experimental Tumor Growth , 2014, PLoS Comput. Biol..

[4]  T. Whelan Use of conventional radiation therapy as part of breast-conserving treatment. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  V. Quaranta,et al.  Integrative mathematical oncology , 2008, Nature Reviews Cancer.

[6]  Eddie Barendsen,et al.  21 years of Biologically Effective Dose , 2022 .

[7]  C. Branch,et al.  Mechanisms of Injury to Normal Tissue after Radiotherapy: A Review , 2014, Plastic and reconstructive surgery.

[8]  Neil F. Johnson,et al.  Model for in vivo progression of tumors based on co-evolving cell population and vasculature , 2011, Scientific reports.

[9]  L. Hlatky,et al.  Acute and fractionated irradiation differentially modulate glioma stem cell division kinetics. , 2013, Cancer research.

[10]  K. Cease,et al.  Time to treatment in patients with stage III non-small cell lung cancer. , 2009, International journal of radiation oncology, biology, physics.

[11]  R. Allison,et al.  Radiation oncology: physics advances that minimize morbidity. , 2014, Future oncology.

[12]  M. Bernstein,et al.  Radiotherapy for brain tumors , 1994, CA: a cancer journal for clinicians.

[13]  Hana M. Dobrovolny,et al.  Differences in predictions of ODE models of tumor growth: a cautionary example , 2016, BMC Cancer.

[14]  Brian O'Sullivan,et al.  Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis , 2006, The Lancet.

[15]  Philip Hahnfeldt,et al.  Quantitative Modeling of Tumor Dynamics and Radiotherapy , 2010, Acta biotheoretica.

[16]  T. Dilling,et al.  Altered fractionation schedules in radiation treatment: a review. , 2014, Seminars in oncology.

[17]  I. Lax,et al.  The role of radiotherapy in treatment of stage I non-small cell lung cancer. , 2003, Lung cancer.

[18]  J. Fowler The linear-quadratic formula and progress in fractionated radiotherapy. , 1989, The British journal of radiology.

[19]  F. J. Richards A Flexible Growth Function for Empirical Use , 1959 .

[20]  P. Hahnfeldt,et al.  The Importance of Spatial Distribution of Stemness and Proliferation State in Determining Tumor Radioresponse , 2009 .

[21]  Thomas E Yankeelov,et al.  Toward a science of tumor forecasting for clinical oncology. , 2015, Cancer research.

[22]  P. Hahnfeldt,et al.  Tumor development under angiogenic signaling: a dynamical theory of tumor growth, treatment response, and postvascular dormancy. , 1999, Cancer research.

[23]  G. Buttazzo,et al.  Selecting Radiotherapy Dose Distributions by Means of Constrained Optimization Problems , 2014, Bulletin of mathematical biology.

[24]  K Hendrickson,et al.  Predicting the efficacy of radiotherapy in individual glioblastoma patients in vivo: a mathematical modeling approach , 2010, Physics in medicine and biology.

[25]  Zhihui Wang,et al.  Cancer dissemination: a consequence of limited carrying capacity? , 2006, Medical hypotheses.

[26]  Philip Hahnfeldt,et al.  The Tumor Growth Paradox and Immune System-Mediated Selection for Cancer Stem Cells , 2013, Bulletin of mathematical biology.

[27]  Michael Meyer-Hermann,et al.  Spatio-Temporal Dynamics of Hypoxia during Radiotherapy , 2015, PloS one.

[28]  Eduardo G. Moros,et al.  Depend on Activated T-cell Traf fi cking and Distribution between Metastatic Lesions , 2016 .

[29]  Nandita Mitra,et al.  Clinical impact of prolonged diagnosis to treatment interval (DTI) among patients with oropharyngeal squamous cell carcinoma. , 2016, Oral oncology.

[30]  J. Folkman,et al.  SELF-REGULATION OF GROWTH IN THREE DIMENSIONS , 1973, The Journal of experimental medicine.

[31]  P. Vaupel,et al.  Tumor hypoxia: causative factors, compensatory mechanisms, and cellular response. , 2004, The oncologist.

[32]  Philip Gerlee,et al.  The model muddle: in search of tumor growth laws. , 2012, Cancer research.

[33]  Masahiro Hiraoka,et al.  Microenvironment and Radiation Therapy , 2012, BioMed research international.

[34]  Mark A. J. Chaplain,et al.  Towards Predicting the Response of a Solid Tumour to Chemotherapy and Radiotherapy Treatments: Clinical Insights from a Computational Model , 2013, PLoS Comput. Biol..

[35]  S. Jonathan Chapman,et al.  Mathematical Models of Avascular Tumor Growth , 2007, SIAM Rev..

[36]  M. Gapany Mature results of a randomized trial of accelerated hyperfractionated versus conventional radiotherapy in head-and-neck cancer , 2011 .

[37]  H M Byrne,et al.  Growth of nonnecrotic tumors in the presence and absence of inhibitors. , 1995, Mathematical biosciences.

[38]  S. Schnell,et al.  A multiscale mathematical model of cancer, and its use in analyzing irradiation therapies , 2006, Theoretical Biology and Medical Modelling.

[39]  A. Anderson,et al.  The evolution of carrying capacity in constrained and expanding tumour cell populations , 2014, Physical biology.